These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29804866)

  • 21. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
    Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
    J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients.
    Raurich JM; Llompart-Pou JA; Ibáñez J; Frontera G; Pérez O; García L; Ayestarán JI
    J Crit Care; 2007 Dec; 22(4):324-9. PubMed ID: 18086404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*.
    Katsenos CS; Antonopoulou AN; Apostolidou EN; Ioakeimidou A; Kalpakou GT; Papanikolaou MN; Pistiki AC; Mpalla MC; Paraschos MD; Patrani MA; Pratikaki ME; Retsas TA; Savva AA; Vassiliagkou SD; Lekkou AA; Dimopoulou I; Routsi C; Mandragos KE;
    Crit Care Med; 2014 Jul; 42(7):1651-7. PubMed ID: 24674923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vipera aspis venom reduces lethality and down-regulates tumor necrosis factor-alpha in a rat model of LPS-induced sepsis.
    Frolkis I; Klein Y; Locker C; Adi N; Dahan E; Uretzsky G; Shapira I; Sorkine P
    Cytokine; 2010 Mar; 49(3):319-24. PubMed ID: 20034812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coli.
    Kopanakis K; Tzepi IM; Pistiki A; Carrer DP; Netea MG; Georgitsi M; Lymperi M; Droggiti DI; Liakakos T; Machairas A; Giamarellos-Bourboulis EJ
    Cytokine; 2013 Jun; 62(3):382-8. PubMed ID: 23602853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low-dose hydrocortisone treatment of catecholamine refractory septic shock].
    Strelzig JD; Stender-Baals M; Lohse TO
    Ugeskr Laeger; 2001 Sep; 163(36):4880-1. PubMed ID: 11571866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.
    Loisa P; Parviainen I; Tenhunen J; Hovilehto S; Ruokonen E
    Crit Care; 2007; 11(1):R21. PubMed ID: 17306016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice.
    Tkalcević VI; Bosnjak B; Pasalić I; Hrvacić B; Situm K; Kramarić MD; Glojnarić I; Eraković Haber V
    Int J Antimicrob Agents; 2008 Aug; 32(2):195-6. PubMed ID: 18571382
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bolus or continuous hydrocortisone--that is the question.
    Weber-Carstens S; Keh D
    Crit Care; 2007; 11(1):113. PubMed ID: 17316466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do low-dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine.
    Sherwin RL; Garcia AJ; Bilkovski R
    J Emerg Med; 2012 Jul; 43(1):7-12. PubMed ID: 22221983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis.
    Chen X; Feng Y; Shen X; Pan G; Fan G; Gao X; Han J; Zhu Y
    J Ethnopharmacol; 2018 Jan; 211():358-365. PubMed ID: 28987599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of the effect of ertapenem in rats with sepsis created by cecal ligation and puncture.
    Göl Serin B; Köse Ş; Yilmaz O; Yildirim M; Akbulut I; Serin Senger S; Akkoçlu G; Diniz G; Serin S
    Ulus Travma Acil Cerrahi Derg; 2019 Sep; 25(5):427-432. PubMed ID: 31475323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
    Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
    Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protective effects of vasoactive intestinal peptide on intestinal lesions induced by endotoxic shock in rat].
    Zhang YC; Yang LP; Tang DH; Zhang YM
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):369-73. PubMed ID: 16780716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
    Valoor HT; Singhi S; Jayashree M
    Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.
    Song XM; Li JG; Wang YL; Hu ZF; Zhou Q; Du ZH; Jia BH
    Shock; 2008 Oct; 30(4):468-72. PubMed ID: 18391858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of pro-inflammatory cytokine suppression and survival by microencapsulated dexamethasone in the treatment of experimental sepsis.
    Uddin MN; Siddiq A; Oettinger CW; D'Souza MJ
    J Drug Target; 2011 Nov; 19(9):752-60. PubMed ID: 21913870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.